Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer

Stanford University

Status: Terminated

Conditions: Bone Cancer

Treatments: Procedure: positron emission tomography/computed tomography; Radiation: fluorine F 18 sodium fluoride

Study type: Interventional

Funder types: Other

Identifiers

NCT01541358

IRB-23082

SU-02162012-9128 (Other Identifier)

NCI-2012-00138 (Registry Identifier)

VAR0074 (Other Identifier)

Details and patient eligibility

About

This clinical trial studies fluorine F-18 sodium fluoride positron emission tomography (PET)/computed tomography (CT) in diagnosing bone tumors in patients with cancer. Diagnostic procedures, such as fluorine F-18 sodium fluoride PET/CT, may help find and diagnose bone cancer

Full description

The objective of the study is to use 18F sodium fluoride (fluorine F-18 sodium fluoride) PET/CT scanning to detect and characterize lesions in patients who have suspected skeletal malignancy. We hypothesize that scanning with 18F-NaF (fluorine F-18 sodium fluoride) is more sensitive for skeletal abnormalities and may better characterize lesions than conventional imaging.

Enrollment: 2 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients referred for evaluation of suspected skeletal cancer
• Patients must understand and voluntarily sign an informed consent form after the contents have been fully explained to them

Exclusion criteria

• Patients who cannot complete a PET/CT scan
• Pregnant women
• Healthy volunteers

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

2 participants in 1 patient group

Diagnostic (fluorine F 18 sodium fluoride PET/CT)

Experimental group

Description:

Patients undergo fluorine F 18 sodium fluoride PET/CT scan.

Treatment:

Radiation: fluorine F 18 sodium fluoride

Procedure: positron emission tomography/computed tomography